Daily News Podcast

Bempedoic acid: funny name, serious LDL lowering

Publish date: March 15, 2019

 

Bempedoic acid safely dropped LDL cholesterol, and now it’s up for FDA approval. Recent trials advance axial spondyloarthritis therapy. Newer antihyperglycemic drugs have distinctive cardiovascular, kidney benefits. And doctors’ prior authorization burden is increasing.
Amazon Alexa
Apple Podcasts
Google Podcasts
Spotify

Recommended Reading

Parental leave inequities: Kirti Magudia and Thomas Ng, Part I
MDedge ObGyn
Trump targets abortion by denying family planning funds
MDedge ObGyn
Will having fewer primary care physicians shorten Americans’ lifespans?
MDedge ObGyn
Cancer-battling breath, Zombie Bambi, and hops as health food
MDedge ObGyn
Esketamine gets the green light for depression
MDedge ObGyn
Ready for universal hepatitis C testing?
MDedge ObGyn
Quitting smoking during pregnancy cuts SUID risk
MDedge ObGyn
Autism risk with in utero infections
MDedge ObGyn
Aspirin and lower risk of COPD flare-up
MDedge ObGyn
Semaglutide plus SGLT2 inhibitors for type 2 diabetes
MDedge ObGyn